Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. - Wikidata - wikimedia - TriplyDB

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

http://www.wikidata.org/entity/Q33981964

about

Hepatitis B vaccination during pregnancy for preventing infant infection Hepatitis B vaccination during pregnancy for preventing infant infection The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG.Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention.Individualized management of pregnant women with high hepatitis B virus DNA levels.The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis.Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta.Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis.Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus.Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials.A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women.Review: hepatitis B immune globulin for prevention of hepatitis B infection.Genetic variant in CXCL13 gene is associated with susceptibility to intrauterine infection of hepatitis B virus.Chronic hepatitis B virus infection and pregnancy.Gender specific medicine in liver diseases: a point of view.Measures to reduce mother-to-child transmission of Hepatitis B virus in China: a meta-analysis.Mother-to-child transmission of HBV: review of current clinical management and prevention strategies.Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.Evaluation of neonatal Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in HBV intrauterine transmission susceptibility.Frequencies of dendritic cells and Toll-like receptor 3 in neonates born to HBsAg-positive mothers with different HBV serological profiles.Risk factors for intrauterine infection with hepatitis B virus.Role of peripheral blood mononuclear cell transportation from mother to baby in HBV intrauterine infection.Unsolved problems and future perspectives of hepatitis B virus vaccination.Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy.Pregnancy and chronic hepatitis B virus infection.The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus.Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: a prospective case-control study.Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment.

P2860

Q24188025-015AE583-C7E0-4A56-9B96-7D51678BCA26 Q24235783-E48B2442-D4D6-47EA-A378-515CBFB8447D Q28073299-254417CB-B6EF-479C-940D-EEE2EBDED87C Q33868020-CC0B84BC-35D3-49AE-BE9F-745F8DE259EA Q34135030-36543B3F-6782-4A21-9212-AA65956D03A5 Q34168470-5262E678-E464-496E-AEFF-78D3D34AEEA2 Q34402956-E4C79DBF-59D9-4C74-A87A-53976D118FA6 Q34575375-8AF1871E-6827-4B79-984C-C68CCCBB8BFB Q34657327-6D9B5A21-D0F5-4BA4-9220-97C0DEFF4052 Q34979125-6002F3BC-CB3A-49AD-989C-0F786AD1C913 Q35069191-5DF865C6-26BB-4050-A867-FB8BE9E6B597 Q35196581-63FF73C2-0314-4E79-A4AB-7240215D08F3 Q35545742-3A899C46-B438-402B-AECA-F27FE89A02A5 Q35840548-CA61977B-D124-49C5-921D-817A45605A28 Q35905968-7740C3FC-3AA4-464B-AD56-153386FB00E2 Q36756841-6A71E635-25AA-4483-9CC0-45478C44FD8B Q36828004-087BA03C-DEFD-4993-AEFF-E399A403A8E9 Q36925448-85FF7895-A20E-42EC-91E3-DB0F43B779F2 Q37613468-B5F56C94-D54C-45B1-9078-B690EEA96D93 Q37617937-FCAE22D7-13C0-4E27-BF00-73260E9644D7 Q38160176-80AE5041-260D-47B3-A057-679295BFA110 Q38222498-D16C53AF-2E4C-4349-B5FB-98B036768247 Q38966352-A14102BC-F5A4-439C-ABEE-2875EB6F00DD Q41666960-3D78D421-D0B8-4E6E-B7DF-C0F60087A5FC Q42223044-000EA3ED-8F9D-45B2-9E46-2FA8CC499FB1 Q42225531-11009566-8616-4EE5-99E8-E18F5B9184AA Q42261584-AF493073-2604-4CD2-8D6C-0A315BDCBE50 Q42412334-496D3B17-0781-4AB4-9FC4-400B4720755D Q44513135-A625E9D2-8EEA-41D3-9134-F06397ECC20C Q45235023-114FE048-F2D7-49F6-8BC7-2DFA5CE74CEC Q45359804-11304782-288A-469E-8493-7B6FAFFD6609 Q45407321-0D056BFA-D4CF-49EC-9887-CCD9AD5EB077 Q47596434-DDE159D9-0EBE-41E3-AC20-4F48602E5297

P2860

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

http://www.wikidata.org/entity/Q33981964

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

@ast

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

@en

type

label

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

@ast

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

@en

prefLabel

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

@ast

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

@en

P1433

Q33981964-5106F4A1-92DF-4F02-B52A-5CA667BCE65C

P1476

Q33981964-49B7C5B8-CE21-4EDA-A8BD-9F429B85D88B

P2093

Q33981964-436DE19C-65CA-4EEA-9AB6-506BD1F4A9E7

Q33981964-53D88F96-506C-4FED-A2B2-9B26C85C690B

Q33981964-8B4EA8C6-7729-440E-BC53-A995AEFC2AA9

Q33981964-8F33AE3B-3CA0-47F6-B880-91A0D4E83197

Q33981964-9130088E-1364-4E2B-9603-0127396A7FC5

Q33981964-AA7F800F-FAEC-4264-BD36-F60D937FB5DC

Q33981964-C621C8C8-D1AD-4490-9E21-3892A18113E5

P2860

Q33981964-342CD850-7B8D-4375-8145-1DF27781FC76

Q33981964-505608C3-FF14-43EE-8F05-E5DFFE0670ED

Q33981964-54FAE88D-53B0-4B2A-9FCE-4DE5EE4AF2D8

Q33981964-5ECE444D-14F0-485D-93AF-DBF46BCB938C

Q33981964-75C31002-5EE0-41C4-B487-E9B25D4EE9E4

Q33981964-A16C7026-253A-4E85-9270-3ED98A8202CA

Q33981964-B7C3718E-6340-4ADC-AE9A-A2F57EE3F473

Q33981964-BA808089-9183-4136-AF94-0633F935A60E

Q33981964-BF4F2D59-E9FC-4DBD-86C5-360EB63BE262

P304

Q33981964-1F17A87D-C6BD-4DC9-A1E6-3FD1C9CBA133

P31

Q33981964-470123C6-15CF-4DA1-894C-7F520F1B517F

P356

Q33981964-11EE852D-C8EF-496A-83B6-28E15F15691F

P407

Q33981964-CDF99582-5213-42E7-85BF-4AA480D01127

P433

Q33981964-BAC640A2-5DE4-4339-9C6D-50A1C9608E2E

P478

Q33981964-C0447C28-2C43-4351-89A3-0B5230890289

P577

Q33981964-7EF953DC-8276-42A8-8177-83069FE7CBDD

P5875

Q33981964-B2A4917C-CE6E-4783-8CC6-4EA726C1AF0B

P698

Q33981964-8CC1DA7B-9463-4001-BB1A-D44070B9E689

P932

Q33981964-72B81561-13DB-4F35-BF6A-4A75586DA5E1

P356

WJG.V10.I21.3215

P1433

World Journal of Gastroenterology

P1476

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

@en

P2093

Ben-Qi Teng

http://www.w3.org/2001/XMLSchema#string

Hong-Ying Hou

http://www.w3.org/2001/XMLSchema#string

Hui-Min Shen

http://www.w3.org/2001/XMLSchema#string

Min-Feng Shi

http://www.w3.org/2001/XMLSchema#string

Xiao-Mao Li

http://www.w3.org/2001/XMLSchema#string

Yue-Bo Yang

http://www.w3.org/2001/XMLSchema#string

Zhong-Jie Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Interruption of HBV intrauterine transmission: a clinical study.

Fetal immunization by a DNA vaccine delivered into the oral cavity.

Progress toward elimination of hepatitis B virus transmission in the United States.

Vertical transmission of hepatitis B virus despite maternal lamivudine therapy.

Hepatitis B vaccination--United States, 1982-2002.

[Mother-child transmission of hepatitis B virus. State of the problem and prevention]

Public health measures to control hepatitis B virus infection in the developing countries of the Asia-Pacific region.

Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors.

Detection of hepatitis B surface antigen in pregnant women attending a public hospital for delivery: implication for vaccination strategy in Bangladesh

P304

3215-3217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V10.I21.3215

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8257106

http://www.w3.org/2001/XMLSchema#string

P698

15457579

http://www.w3.org/2001/XMLSchema#string

P932

4611277

http://www.w3.org/2001/XMLSchema#string